Assessment of Anti-Obesity and Hypolipidemic Effects of Bombax Ceiba Flower Extracts In Experimental Rats
International Journal of Drug Delivery Technology · 12.06.2026 · 16 (53s)
DOI: 10.25258/ijddt.16.53s.57 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 12.06.2026. Verfasst von Manvendra Shukla und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Obesity is a chronic metabolic disorder associated with excessive fat accumulation, dyslipidemia, oxidative stress, and increased risk of cardiovascular diseases. The present study was designed to evaluate the physicochemical properties, phytochemical constituents, total phenolic content, and anti-obesity potential of Bombax ceiba flower extracts using a high fat diet (HFD)-induced obesity model in Wistar albino rats. Preliminary phytochemical screening revealed the presence of flavonoids, tannins, phenolics, triterpenes, steroids, proteins, carbohydrates, and saponins in different extracts. Total phenolic content estimation by Folin–Ciocalteu method showed that the methanolic extract possessed the highest phenolic content (97.14 ± 4.28 mg GAE/g). Anti-obesity activity was evaluated in HFD-induced obese rats for 45 days. Animals treated with methanolic extract of Bombax ceiba (MBC) and aqueous extract (ABC) at doses of 150 and 300 mg/kg showed significant reduction in body weight gain, food intake, liver weight, and epididymal adipose tissue weight compared with the HFD group. Biochemical analysis demonstrated significant improvement in serum lipid profile, including reduction in total cholesterol, triglycerides, LDL, atherogenic index, and improvement in HDL levels. The extracts also reduced elevated liver enzyme markers such as SGOT, SGPT, and bilirubin, indicating hepatoprotective activity. Among all treatments, the methanolic extract at 300 mg/kg exhibited the most significant anti-obesity effect, comparable to the standard drug orlistat. The findings suggest that Bombax ceiba flower extracts possess promising anti-obesity, and hypolipidemic, activities, possibly due to the presence of phenolic and flavonoid constituents. The study supports the therapeutic potential of Bombax ceiba as a natural agent for the management of obesity and associated metabolic disorders.
Zitieren
APA
Shukla, M., & Yaduwanshi, P. S. (2026). Assessment of Anti-Obesity and Hypolipidemic Effects of Bombax Ceiba Flower Extracts In Experimental Rats. International Journal of Drug Delivery Technology, 16(53s). https://doi.org/10.25258/ijddt.16.53s.57
Vancouver
Shukla M, Yaduwanshi PS. Assessment of Anti-Obesity and Hypolipidemic Effects of Bombax Ceiba Flower Extracts In Experimental Rats. International Journal of Drug Delivery Technology. 2026;16(53s). doi:10.25258/ijddt.16.53s.57
BibTeX
@article{Shukla2026,
author = {Shukla, Manvendra and Yaduwanshi, Phool Singh},
title = {Assessment of Anti-Obesity and Hypolipidemic Effects of Bombax Ceiba Flower Extracts In Experimental Rats},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {53s},
doi = {10.25258/ijddt.16.53s.57}
}
EUVIMED